Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype

NCT01078870 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lexapro
DRUG: Cymbalta
DRUG: Placebo

Sponsor

National Taiwan University Hospital